Skip to main content
Equibles
DBVT logo

DBVT · DBV Technologies S.A.

Track DBVT — free

Use DBVT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about DBVT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$14.02 -0.01 (-0.07%) At close · Aug 14
Market Cap
$4.15B
Shares
296.06M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$14.02 Open$13.95 Day$13.69–14.07 52W close$8.70–24.54 Avg vol 30d338K Short int1.8M · 0.6% float · 5.0d Short vol58% Last earningsJul 16, 2026 DataJun 2024–Aug 2026 Filing10-Q · Jul 16

Raw chart and full-history price indicators begin at the captured split on Jun 7, 2024; bars on opposite sides are not compared.

Up next

Next earnings call
Nov 3, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Jul 16, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −23%
      below
      Price vs 50-day avg −8%
      below
      RSI (14) 45
      neutral
      MACD trend Positive
      52-week position 34%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −5%
      trailing
      6-month return −34%
      trailing
      YTD return −27%
      this year
      Relative strength −48%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $15 › 200d $18 — 200d above 50d
      Institutional flow Accumulating
      +8% holders QoQ · +17 funds added
      Insider flow Distributing
      Net -$1.3K over 90 days · 100% sells
      Short interest Rising
      0.62% of float · ▲ +25.7% MoM · 5.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      78 holders — near 3-yr high, broad support
      Squeeze score 46
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +36%
      Y/Y
      EPS growth +10%
      Y/Y
      Free cash flow $-121.7M
      Balance sheet $192.7M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 75%
      annualized · 1-yr
      Max drawdown −45%
      past year
      ATR 5.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Neutral
      2 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −23% Bearish
      Price vs 50-day avg
      −8% Bearish
      RSI (14)
      45 Neutral
      MACD trend
      Positive Bullish
      52-week position
      34% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Mixed
      Trend (MA cross) No cross
      50d $15 › 200d $18 — 200d above 50d
      Institutional flow Accumulating
      +8% holders QoQ · +17 funds added
      Insider flow Distributing
      Net -$1.3K over 90 days · 100% sells
      Short interest Rising
      0.62% of float · ▲ +25.7% MoM · 5.0 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      78 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $9 Now $14 · 34% Range high $25
      vs 200-day avg -23% vs 50-day avg -8%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      DBVT
      DBV Technologies S.A.
      this stock
      		$4.15B -26.9% +35.8% — 0.6%
      ONC
      BeOne Medicines Ltd.
      		 $513.62B +14.4% +22179.2% 789.7 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $128.19B +11.6% +46.2% 29.5 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $82.72B +4.1% +20.8% 19.9 3.3%
      ARGX
      Argenx SE
      		 $52.94B +1.2% — — 2.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      78
      % held
      7.3%
      Net QoQ
      +343.8K sh
      Top holder
      MPM BIOIMPACT LLC
      Held Float
      View
      Held by Funds
      Fund positions
      11
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      1.8M
      Days to cover
      5.0d
      Change
      +378.1K sh
      View
      Short Volume
      Short vol %
      58%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      8.3K
      Value
      $144.5K
      As of
      Jul 8, 2026
      View
      Off-Exchange
      Off-exchange %
      39.9%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$1.3K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $5.6M
      Net income (FY)
      $-146.9M
      EPS diluted
      $-1.05
      View
      Filings
      SEC Filings
      Latest
      Investor Event Transcript
      Filed
      Jul 23, 2026
      This year
      18
      View
      Exempt Offerings
      Offering
      $306.9M
      Filed
      Apr 17, 2025
      View
      Earnings & Events
      Earnings Calls
      Last call
      Jul 23, 2026
      View
      Investor Relations
      Upcoming events
      1
      View

      Performance

      Raw-price comparisons begin at the captured split on Jun 7, 2024; windows that need an earlier baseline remain unavailable.

      5D 20D 120D MTD YTD
      DBVT +4.0% -4.6% -34.0% +3.9% -26.9%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +3.6% -9.1% -47.7% -0.1% -40.7%
      Key facts CIK 1613780 CUSIP 23306J309 13F (30d) 75 filings 74 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)